Processing

Please wait...

Settings

Settings

Goto Application

1. WO2003035059 - SPERMICIDES

Publication Number WO/2003/035059
Publication Date 01.05.2003
International Application No. PCT/GB2002/004813
International Filing Date 24.10.2002
Chapter 2 Demand Filed 23.04.2003
IPC
A61K 31/4015 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4015having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
C07D 207/452 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
207Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
02with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
44having three double bonds between ring members or between ring members and non-ring members
444having two doubly-bound oxygen atoms directly attached in positions 2 and 5
448with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
452with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
CPC
A61K 31/4015
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4015having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
A61P 15/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15Drugs for genital or sexual disorders
16Masculine contraceptives
C07D 207/452
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
207Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
02with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
44having three double bonds between ring members or between ring members and non-ring members
444having two doubly-bound oxygen atoms directly attached in positions 2 and 5
448with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
452with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
Applicants
  • SSL INTERNATIONAL PLC [GB]/[GB] (AllExceptUS)
  • SOLANKI, Suren [GB]/[GB] (UsOnly)
  • POTTER, William, Duncan [GB]/[GB] (UsOnly)
  • ANDERSON, Lorraine [GB]/[GB] (UsOnly)
Inventors
  • SOLANKI, Suren
  • POTTER, William, Duncan
  • ANDERSON, Lorraine
Agents
  • CORNISH, K., V., J.
Priority Data
0125659.325.10.2001GB
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) SPERMICIDES
(FR) SPERMICIDES
Abstract
(EN) The present invention relates to the use of maleimide derivatives as spermicidal agents. In particular it relates to the use of a maleimide compound of formula (I): wherein R is any group with the proviso that the maleimide is not N-ethylmaleimide, as a spermicide. The invention further provides novel these compounds and their use in medicine. The invention also relates to spermicidal formulations containing maleimide derivatives.
(FR) Cette invention porte sur l'utilisation de dérivés maléimides comme agents spermicides. Elle porte en particulier sur l'utilisation d'un composé maléimide comme spermicide représenté par la formule (I), dans laquelle R représente un groupe quelconque à condition que le maléimide ne soit pas N-éthylmaléimide. Cette invention concerne également de nouveaux composés et leur utilisation dans le domaine médical. En outre, cette invention concerne des compositions spermicides renfermant des dérivés maléimides.
Latest bibliographic data on file with the International Bureau